What's New
Welcome to the What’s New section of the National Fibromyalgia Research Association’s website. In this section we’ll highlight new treatments, including medications that show promise in helping to alleviate fibromyalgia symptoms. Or, we may highlight just beginning research studies and the researchers involved.
You will also find news regarding fibromyalgia advocacy, special conferences and events, new publications and news from patient organizations. On occasion, we will highlight researchers and other medical professionals we feel others should hear about. Check back often. Whether you are a medical professional, researcher, patient or family member, we’ll be highlighting something that will interest you!
Click here for the most recent posting to What’s New. For a review of previous topics, click on the date of the item in the What’s New Archive.
What’s New Archive
June 2007
–
Medical Education Grant . . .
Eli Lilly and Company has awarded NFRA $46,500 to support the Fibromyalgia Assembly sponsored by NFRA at PAINWeek 2007.
May 2007
–
Two NEW articles . . .
We’d like you to know about – the results of the treatment of cervical myelopathy in patients also diagnosed with fibromyalgia and the first published randomized, double-blind, placebo-controlled research study of gabapentin in fibromyalgia.
April 2007
–
Emma Z's Letter
Emma Z. has found a way to show her love for her mom who has fibromyalgia and support fibromyalgia research. Maybe you can find your own way to make a difference!
December 2006
–
The Year in Review
The National Fibromyalgia Research Association staff was busy in 2006.
Read about what we accomplished to accomplish our mission of education, treatment and finding a cure for fibromyalgia.
September 2006 – The Fibromyalgia and Central Nervous System Symposium
Our fifth researcher’s symposium, Fibromyalgia and the Central Nervous System Symposium was held in Salem, Oregon in September 2006. Seventeen researchers made presentations over the two days that were facilitated by Dr. Robert Bennett. DVDs of the presentations are available through our shopping cart.
June 2006 – Andrew Holman, MD, rheumatologist, Renton, Washington
Our first What’s New item highlights Dr. Andrew Holman and his work with dopamine agonists. His recently published article regarding positive research results for the treatment of fibromyalgia using Pramipexole made national news. Included is the abstract of this study.
